Realist Ventures

Realist Ventures is a venture capital firm established in 2018 and located in Stamford, Connecticut. The firm focuses on investing in bold founders and innovative ideas, targeting the development, seed, and early stages of companies. Realist Ventures primarily seeks minority investments in a range of sectors, including biotechnology, software, technology, and software as a service. By concentrating on early-stage companies, Realist Ventures aims to support the growth of promising businesses that have the potential to make a significant impact in their respective markets.

Patricia Barakett

Co-Founder and General Partner

4 past transactions

GRID

Seed Round in 2022
GRID is a tech startup unleashing the power of no code for video games. The team is building Breshna.io, a platform that empowers users to create, share and monetize their own purposeful web3 video games, with no code and at lightning speed.

Career Karma

Seed Round in 2019
Career Karma is the easiest way to find a job training program online. Over 1 million workers navigate their careers every month through advice and coaching. By offering free coaching and peer mentorship, Career Karma has grown to over 150,000 members from every background and profession. Through its directory of 9,000 boot camps and trade schools, career switchers discover training programs by comparing courses and reading student reviews. The Career Karma mobile app makes your decision even easier. In the app, you can connect with current students and alumni to find your ideal program and get prepared for admission.

Shipsi

Seed Round in 2018
Shipsi empowers any retailer with the ability to offer an easy “instant shipping” option on their checkout page—without worrying about logistics. They use existing infrastructure and last-mile delivery networks to help customers order now AND get it now. Shipsi was founded in 2017 and is headquartered in Austin, TX.

Valisure

Venture Round in 2018
Valisure is launching the first digital pharmacy to chemically validate medications for quality and consistency. In response to rising concerns about counterfeit medications, insurance-mandated generics and overseas manufacturing in India and China, Valisure has developed novel, laser-based analytical technology that enables them to deliver medications to consumers that include a certificate of analysis specifying batch-validated dosage, inactive ingredients and other important properties. Medications are dispensed from Valisure only after the batch passes rigorous chemical analysis at the Valisure Lab. Valisure’s staff of Harvard and Yale-trained scientists strive to bring consumers the utmost quality. Valisure has ISO 17025 accreditation and is DEA and FDA registered.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.